Margin for OTC products is too high, says Pimco's De Leon

Regulators need to balance setting margin requirements

Incoming margin regimes for over-the-counter derivatives are too high while those for the futures market may be too low, according to William De Leon, global head of portfolio risk management at Pimco. The too-high OTC margin requirements could distort markets for eligible collateral, he says.

The issue hinges on assumptions about how long it will take a central counterparty (CCP) to liquidate the portfolio of a defaulted member or client. That assumption drives the amount of initial margin a

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact customer services -, or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to FX Markets? View our subscription options

You need to sign in to use this feature. If you don’t have a FX Markets account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: